$SMG
SCOTTS MIRACLE-GRO CO

2013 Q3 Form 10-Q Financial Statement

#000154638013000026 Filed on August 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2012 Q2
Revenue $433.6M $1.055B
YoY Change 8.08% -6.06%
Cost Of Revenue $302.9M $685.7M
YoY Change 2.26% 3.02%
Gross Profit $130.1M $369.0M
YoY Change 23.9% -20.44%
Gross Profit Margin 30.0% 34.98%
Selling, General & Admin $124.9M $197.6M
YoY Change -16.17% -8.6%
% of Gross Profit 96.0% 53.55%
Research & Development $12.50M $13.20M
YoY Change -1.49%
% of Gross Profit 9.61% 3.58%
Depreciation & Amortization $17.00M $16.60M
YoY Change 9.68% 8.5%
% of Gross Profit 13.07% 4.5%
Operating Expenses $137.2M $197.6M
YoY Change -8.35% -8.6%
Operating Profit -$7.100M $170.2M
YoY Change -84.12% -30.7%
Interest Expense -$11.30M $16.60M
YoY Change -5.83% 20.29%
% of Operating Profit 9.75%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$29.80M $153.6M
YoY Change -47.44% -33.74%
Income Tax -$10.60M $57.20M
% Of Pretax Income 37.24%
Net Earnings -$19.40M $93.30M
YoY Change -51.62% -47.47%
Net Earnings / Revenue -4.47% 8.84%
Basic Earnings Per Share -$0.31 $1.53
Diluted Earnings Per Share -$0.31 $1.50
COMMON SHARES
Basic Shares Outstanding 62.00M shares 61.10M shares
Diluted Shares Outstanding 62.00M shares 62.20M shares

Balance Sheet

Concept 2013 Q3 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $129.8M $132.3M
YoY Change -1.59% 2.8%
Cash & Equivalents $129.8M $132.3M
Short-Term Investments
Other Short-Term Assets $33.00M $130.6M
YoY Change 1.85% -20.61%
Inventory $324.9M $469.3M
Prepaid Expenses
Receivables $206.6M $516.7M
Other Receivables $12.90M $0.00
Total Short-Term Assets $881.0M $1.346B
YoY Change -11.9% -32.41%
LONG-TERM ASSETS
Property, Plant & Equipment $422.3M $387.7M
YoY Change -1.19% -2.12%
Goodwill $315.1M $309.1M
YoY Change 1.84% 1.08%
Intangibles $284.4M $308.7M
YoY Change -7.39% -10.44%
Long-Term Investments $0.00
YoY Change
Other Assets $34.40M $32.50M
YoY Change 12.79% -10.71%
Total Long-Term Assets $1.056B $1.038B
YoY Change -1.69% -4.16%
TOTAL ASSETS
Total Short-Term Assets $881.0M $1.346B
Total Long-Term Assets $1.056B $1.038B
Total Assets $1.937B $2.384B
YoY Change -6.61% -22.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $137.7M $242.8M
YoY Change -9.59% -33.64%
Accrued Expenses $169.6M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $92.40M $90.80M
YoY Change 6060.0% -88.12%
Total Short-Term Liabilities $509.8M $810.2M
YoY Change 17.57% -50.57%
LONG-TERM LIABILITIES
Long-Term Debt $478.1M $680.4M
YoY Change -38.79% 63.56%
Other Long-Term Liabilities $238.8M $219.5M
YoY Change -7.37% -4.98%
Total Long-Term Liabilities $716.9M $899.9M
YoY Change -30.99% 39.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $509.8M $810.2M
Total Long-Term Liabilities $716.9M $899.9M
Total Liabilities $1.227B $1.710B
YoY Change -16.69% -25.19%
SHAREHOLDERS EQUITY
Retained Earnings $703.4M $690.3M
YoY Change 11.62% 20.41%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $312.6M $359.2M
YoY Change -10.58% 158.42%
Treasury Stock Shares 6.100M shares 7.000M shares
Shareholders Equity $710.5M $674.0M
YoY Change
Total Liabilities & Shareholders Equity $1.937B $2.384B
YoY Change -6.61% -22.46%

Cashflow Statement

Concept 2013 Q3 2012 Q2
OPERATING ACTIVITIES
Net Income -$19.40M $93.30M
YoY Change -51.62% -47.47%
Depreciation, Depletion And Amortization $17.00M $16.60M
YoY Change 9.68% 8.5%
Cash From Operating Activities $198.9M $735.5M
YoY Change 419.32% -269.35%
INVESTING ACTIVITIES
Capital Expenditures -$17.40M -$13.30M
YoY Change -42.76% -18.9%
Acquisitions
YoY Change
Other Investing Activities $100.0K -$7.000M
YoY Change -50.0% -102.8%
Cash From Investing Activities -$17.30M -$20.30M
YoY Change -42.72% -108.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -162.8M -704.6M
YoY Change 1465.38% -380.49%
NET CHANGE
Cash From Operating Activities 198.9M 735.5M
Cash From Investing Activities -17.30M -20.30M
Cash From Financing Activities -162.8M -704.6M
Net Change In Cash 18.80M 10.60M
YoY Change -917.39% -79.01%
FREE CASH FLOW
Cash From Operating Activities $198.9M $735.5M
Capital Expenditures -$17.40M -$13.30M
Free Cash Flow $216.3M $748.8M
YoY Change 214.85% -279.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
152300000 USD
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
242800000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
230700000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
330900000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
482400000 USD
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
516700000 USD
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
542600000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
579100000 USD
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
533700000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-87300000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-84300000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-70700000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
7300000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
8100000 USD
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10500000 USD
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6200000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000000 USD
CY2013Q2 us-gaap Assets
Assets
2362300000 USD
CY2012Q3 us-gaap Assets
Assets
2074400000 USD
CY2012Q2 us-gaap Assets
Assets
2384100000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
1000000000 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
1346100000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
1308500000 USD
CY2013Q2 us-gaap Business Acquisition Cost Of Acquired Entity Purchase Price
BusinessAcquisitionCostOfAcquiredEntityPurchasePrice
7200000 USD
smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
7400000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
800000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
smg Restructuring Reserve Period Expense And Other Related Charges
RestructuringReservePeriodExpenseAndOtherRelatedCharges
8700000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131900000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130900000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
132300000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105400000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26500000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1400000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.300
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.975
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.900
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.325
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4375
CY2012Q2 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
413600000 USD
CY2012Q3 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
408600000 USD
CY2013Q2 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
401800000 USD
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61800000 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61300000 shares
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61200000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61800000 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61200000 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61300000 shares
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
97200000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
150300000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
183500000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
150000000 USD
us-gaap Contract Revenue Cost
ContractRevenueCost
15000000 USD
CY2013Q2 us-gaap Contract Revenue Cost
ContractRevenueCost
5000000 USD
us-gaap Contract Revenue Cost
ContractRevenueCost
15000000 USD
CY2012Q2 us-gaap Contract Revenue Cost
ContractRevenueCost
5000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1520300000 USD
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
685700000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1568200000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
704800000 USD
CY2013Q2 us-gaap Fees And Commissions Other
FeesAndCommissionsOther
40500000 USD
us-gaap Debt Instrument Covenant Compliance
DebtInstrumentCovenantCompliance
The Company was in compliance with the terms of all debt covenants at June 29, 2013.
us-gaap Depreciation
Depreciation
39600000 USD
us-gaap Depreciation
Depreciation
41000000 USD
CY2012Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-27200000 USD
CY2013Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-12000000 USD
CY2012Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-27800000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.92
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.40
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.89
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.37
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.37
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
700000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-4900000 USD
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.372
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.366
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.372
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.365
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4100000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
700000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4000000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
700000 USD
CY2013Q2 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
0 USD
CY2012Q2 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
USD
CY2012Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
0 USD
CY2013Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2012Q2 us-gaap Equity Method Investments
EquityMethodInvestments
USD
CY2012Q3 us-gaap Equity Method Investments
EquityMethodInvestments
USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1000000 USD
us-gaap Fees And Commissions Other
FeesAndCommissionsOther
67900000 USD
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
0 USD
CY2012Q2 us-gaap Fees And Commissions Other
FeesAndCommissionsOther
38200000 USD
us-gaap Fees And Commissions Other
FeesAndCommissionsOther
71600000 USD
CY2012Q2 us-gaap Goodwill
Goodwill
309100000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
315200000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
309400000 USD
us-gaap Gross Profit
GrossProfit
856300000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
441800000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
369000000 USD
us-gaap Gross Profit
GrossProfit
851600000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
148200000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
179800000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
149800000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
96400000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
283500000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
153600000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
233400000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
238500000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.40
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.91
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.45
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.58
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.88
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.37
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.55
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.42
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3100000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3200000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
700000 USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
700000 USD
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3100000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-3200000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.05
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
CY2013Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2012Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
USD
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-100000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
57200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
103700000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
88700000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18600000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-29400000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
97100000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
97600000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
356500000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
293500000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-24300000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
79500000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
176800000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
178400000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
4800000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
17100000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12200000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15400000 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-5000000 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-14200000 USD
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
307100000 USD
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
308700000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
297600000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
16600000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
16800000 USD
us-gaap Interest Expense
InterestExpense
47900000 USD
us-gaap Interest Expense
InterestExpense
49800000 USD
us-gaap Interest Paid Net
InterestPaidNet
45600000 USD
us-gaap Interest Paid Net
InterestPaidNet
48800000 USD
CY2012Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
284600000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
235000000 USD
CY2012Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
224600000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
414900000 USD
CY2012Q2 us-gaap Inventory Net
InventoryNet
469300000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
385800000 USD
CY2012Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
147600000 USD
CY2012Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
142000000 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
111300000 USD
CY2013Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
20100000 USD
CY2012Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
21000000 USD
CY2012Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
26300000 USD
CY2012Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
48300000 USD
CY2012Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
37100000 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
39500000 USD
CY2013Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
23300000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
1472500000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
1620500000 USD
CY2012Q2 us-gaap Liabilities
Liabilities
1710100000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2384100000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2362300000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2074400000 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
810200000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
433600000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
846400000 USD
CY2013Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
1533800000 USD
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
713600000 USD
CY2012Q3 us-gaap Long Term Debt
LongTermDebt
782600000 USD
CY2012Q2 us-gaap Long Term Debt
LongTermDebt
771200000 USD
CY2012Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1500000 USD
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
165500000 USD
CY2012Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
90800000 USD
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
781100000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
548100000 USD
CY2012Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
680400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-68900000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46900000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONTINGENCIES</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management regularly evaluates the Company&#8217;s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers&#8217; compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance reserves are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, its assessment of contingencies is reasonable and related reserves, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company&#8217;s financial condition, results of operations or cash flows. The Company's identified contingencies include the matters set out below.</font></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Regulatory Matters</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June&#160;29, 2013</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> was accrued in the &#8220;Other liabilities&#8221; line in the Condensed Consolidated Balance Sheet for compliance-related environmental actions, the majority of which is for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.</font></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, the Company has been named as a defendant in four putative class actions filed on and after June 27, 2012, which have now been consolidated in the United States District Court for the Southern District of California as </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Morning Song Bird Food Litigation</font><font style="font-family:inherit;font-size:10pt;">, Lead Case No. 3:12-cv-01592-JAH-RBB. The plaintiffs allege various statutory and common law claims associated with the Company's sale of wild bird food products and a plea agreement entered into in previously pending government proceedings associated with such sales. The plaintiffs seek on behalf of themselves and various purported class members monetary damages, restitution, injunctive relief, declaratory relief, attorney's fees, interest and costs. The Company intends to vigorously defend the consolidated action. Given the early stages of the action, the Company cannot make a determination as to whether it could have a material effect on the Company's financial condition, results of operations or cash flows and has not recorded any accruals with respect thereto.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company&#8217;s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs&#8217; contacts with the Company or its products. The Company believes that the claims against it are without merit and is vigorously defending against them. It is not currently possible to reasonably estimate a probable loss, if any, associated with these cases and, accordingly, no reserves have been recorded in the Company&#8217;s Consolidated Financial Statements. The Company is reviewing agreements and policies that may provide insurance coverage or indemnity as to these claims and is pursuing coverage under some of these agreements and policies, although there can be no assurance of the results of these efforts. There can be no assurance that these cases, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-117800000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
115100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
143100000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
93300000 USD
us-gaap Net Income Loss
NetIncomeLoss
180500000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
148200000 USD
us-gaap Net Income Loss
NetIncomeLoss
146600000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
288300000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
331400000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
250200000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
170200000 USD
CY2013Q2 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
200000 USD
CY2012Q2 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
200000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
600000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
600000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30500000 USD
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
32500000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31200000 USD
CY2013Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
900000 USD
CY2012Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
1500000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
3600000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
5100000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
300000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
6400000 USD
CY2013Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
4800000 USD
CY2012Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
-2000000 USD
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
4400000 USD
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3600000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8500000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-500000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3400000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3000000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3900000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2100000 USD
CY2012Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
476600000 USD
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
450200000 USD
CY2012Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
279800000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
226000000 USD
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
219500000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
257800000 USD
CY2013Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2012Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
9600000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-6600000 USD
CY2012Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2200000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3500000 USD
CY2013Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
4900000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
7500000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17500000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
60700000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
55500000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3200000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7000000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42700000 USD
CY2012Q3 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
0 USD
CY2013Q2 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
199900000 USD
CY2012Q2 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
97200000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
135000000 USD
CY2012Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
122300000 USD
CY2012Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
130600000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1531900000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1284900000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5300000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16600000 USD
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
387700000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
409800000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427400000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
51500000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
69000000 USD
CY2013Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
16900000 USD
CY2012Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
27800000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1347500000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1549400000 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
8500000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
4600000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
5300000 USD
CY2012Q3 us-gaap Restructuring Reserve
RestructuringReserve
10200000 USD
CY2013Q2 us-gaap Restructuring Reserve
RestructuringReserve
13900000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
7100000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
6700000 USD
CY2012Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
-400000 USD
CY2013Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
7000000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
750000000 USD
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
690300000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
630200000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1054900000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1148100000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2373500000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2424900000 USD
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6800000 shares
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
521000000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
197600000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
189500000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
557000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10600000 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1700000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1900000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
17000000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
17400000 USD
us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P4Y
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
7800000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
401200000 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
674000000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
601900000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
741800000 USD
CY2012Q2 us-gaap Treasury Stock Value
TreasuryStockValue
359200000 USD
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
6400000 shares
CY2012Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
7000000 shares
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
325700000 USD
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
349600000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and related disclosures. Although these estimates are based on management&#8217;s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.</font></div></div>
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62200000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62000000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61700000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61700000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61100000 shares
CY2011Q2 smg Additional Shares Authorized For Repurchase Value
AdditionalSharesAuthorizedForRepurchaseValue
200000000 USD
smg Aggregate Stock Repurchase Program Authorized Repurchase Amount
AggregateStockRepurchaseProgramAuthorizedRepurchaseAmount
700000000 USD
smg Commission Income Expense Net
CommissionIncomeExpenseNet
52300000 USD
CY2012Q2 smg Commission Income Expense Net
CommissionIncomeExpenseNet
33000000 USD
CY2013Q2 smg Commission Income Expense Net
CommissionIncomeExpenseNet
35300000 USD
smg Commission Income Expense Net
CommissionIncomeExpenseNet
56000000 USD
CY2010Q3 smg Common Stock Repurchase Authorized Amount1
CommonStockRepurchaseAuthorizedAmount1
500000000 USD
CY2013Q2 smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
0 USD
CY2012Q2 smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
200000 USD
smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
0 USD
smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
400000 USD
smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
0 USD
CY2013Q2 smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
1500000 USD
CY2012Q2 smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
0 USD
smg Cost Of Sales Impairment Restructuring And Other Charges
CostOfSalesImpairmentRestructuringAndOtherCharges
1600000 USD
smg Gain Loss On Sale Of Long Lived Assets
GainLossOnSaleOfLongLivedAssets
-800000 USD
smg Gain Loss On Sale Of Long Lived Assets
GainLossOnSaleOfLongLivedAssets
100000 USD
smg Grant Of Share Based Compensation Awards
GrantOfShareBasedCompensationAwards
709301.000000 shares
smg Grant Of Share Based Compensation Awards
GrantOfShareBasedCompensationAwards
386824.000000 shares
CY2013Q2 smg Intercompany Assets
IntercompanyAssets
0 USD
CY2012Q2 smg Intercompany Assets
IntercompanyAssets
USD
CY2012Q3 smg Intercompany Assets
IntercompanyAssets
USD
CY2013Q2 smg Intercompany Liabilities
IntercompanyLiabilities
0 USD
CY2012Q2 smg Intercompany Liabilities
IntercompanyLiabilities
USD
CY2012Q3 smg Intercompany Liabilities
IntercompanyLiabilities
0 USD
CY2013Q2 smg Interest Coverage Ratio
InterestCoverageRatio
5.79
CY2013Q2 smg Leverage Ratio
LeverageRatio
2.46
smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
125000000 USD
CY2013Q2 smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
52200000 USD
CY2012Q2 smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
60800000 USD
smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
103800000 USD
smg Payments For Proceeds From Intercompany Advances From Financing Activities
PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities
0 USD
smg Payments For Proceeds From Intercompany Advances From Financing Activities
PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities
USD
smg Payments For Restructuring And Other
PaymentsForRestructuringAndOther
5000000 USD
smg Proceeds From Sale Of Long Lived Assets
ProceedsFromSaleOfLongLivedAssets
500000 USD
smg Proceeds From Sale Of Long Lived Assets
ProceedsFromSaleOfLongLivedAssets
3500000 USD
smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
0 USD
CY2012Q2 smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
3800000 USD
CY2013Q2 smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
0 USD
CY2013Q2 smg Regulatory Matters Other Liabilities
RegulatoryMattersOtherLiabilities
3700000 USD
dei Document Period End Date
DocumentPeriodEndDate
2013-06-29
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000825542
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61879752 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
SCOTTS MIRACLE-GRO CO
dei Trading Symbol
TradingSymbol
SMG

Files In Submission

Name View Source Status
0001546380-13-000026-index-headers.html Edgar Link pending
0001546380-13-000026-index.html Edgar Link pending
0001546380-13-000026.txt Edgar Link pending
0001546380-13-000026-xbrl.zip Edgar Link pending
exhibit103smg06292013q3f13.htm Edgar Link pending
exhibit311smg06292013q3f13.htm Edgar Link pending
exhibit312smg06292013q3f13.htm Edgar Link pending
exhibit32smg06292013q3f13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
porterconsultingagree_image1.jpg Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R57.xml Edgar Link unprocessable
R58.htm Edgar Link pending
R58.xml Edgar Link unprocessable
R59.htm Edgar Link pending
R59.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R60.htm Edgar Link pending
R60.xml Edgar Link unprocessable
R61.htm Edgar Link pending
R61.xml Edgar Link unprocessable
R62.htm Edgar Link pending
R62.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
smg-0629201310q3f13.htm Edgar Link pending
smg-20130629.xml Edgar Link completed
smg-20130629.xsd Edgar Link pending
smg-20130629_cal.xml Edgar Link unprocessable
smg-20130629_def.xml Edgar Link unprocessable
smg-20130629_lab.xml Edgar Link unprocessable
smg-20130629_pre.xml Edgar Link unprocessable